News
Startups Flock to Turn Young Blood Into an Elixir of Youth
September 6, 2018 /
While much work remains to be done on how this regenerative process actually works, Stanford’s parabiosis studies have since inspired the creation of a handful of ambitious startups aimed at producing similarly dramatic effects in humans. Today, the latest young-blood medicine-maker, Elevian, emerged from stealth with $5.5 million from investors including Peter Diamandis, one of the more prominent faces in the Silicon Valley "death disruption" scene.
Megan Molteni
https://www.wired.com/story/startups-flock-to-turn-young-blood-into-an-elixir-of-youth/
MATR Supporters (view all)
Posted in: Cool Stuff That's Coming
Sorry, we couldn't find any posts. Please try a different search.